3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
9
Breast Neoplasms
6
Ovarian Neoplasms
5
Prostatic Neoplasms
3
Papillomavirus Infections
3
Endometrial Neoplasms
3
Triple Negative Breast Neoplasms
2
Genital Neoplasms, Female
2
Fallopian Tube Neoplasms
2
Colorectal Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Dysplasia
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Stage IB Cervical Cancer FIGO 2018
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Neoplasms by Site
1
Neoplasms
1
Lung Neoplasms
1
Kidney Neoplasms
1
Gynecologic Cancer
1
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
1
Disease
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Interventions
Fulvestrant
3
cobimetinib
2
anlotinib
2
Bevacizumab
2
trametinib
1
selinexor
1
ribociclib
1
relacorilant
1
palbociclib
1
osimertinib
1
olaparib
1
niraparib
1
nintedanib
1
exemestane
1
enzalutamide
1
dabrafenib
1
atezolizumab
1
alectinib
1
abemaciclib
1
Watchful Waiting
1
Vemurafenib
1
Transurethral Resection of Prostate
1
Trabectedin
1
Tamoxifen
1
STX-478
1
Pregnancy Tests
1
Pemetrexed
1
Metformin
1
Letrozole
1
Imlunestrant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms by Site
×
Educational Status
×
Gynecologic
×
Clear all
NCT04679675
2023-09-18
STEP
Kaiser Permanente
Phase NA
Completed
32,771 enrolled
11 charts